Indian Journal of Pharmacology Home 

EDUCATIONAL FORUM
[View FULLTEXT] [Download PDF]
Year : 2019  |  Volume : 51  |  Issue : 4  |  Page : 243--247

Vaccine pharmacovigilance in India: Current context and future perspective

Bikash Ranjan Meher 
 Department of Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India

Correspondence Address:
Dr. Bikash Ranjan Meher
Department of Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, Odisha
India

Pharmacovigilance of vaccines is of paramount importance to promote the safe use of vaccines among their recipients. India launched the Adverse Events Following Immunization (AEFI) surveillance program in 1986 for monitoring suspected adverse events following immunization and since then, the AEFI surveillance guideline has been updated periodically, with the latest being in 2015. The successful AEFI surveillance program in India required the concerted effort of all stakeholders such as National AEFI Secretariat, National Technical Collaborating Centre, Central Drug Standard Control Organization, marketing authorization holder, and health-care professionals.


How to cite this article:
Meher BR. Vaccine pharmacovigilance in India: Current context and future perspective.Indian J Pharmacol 2019;51:243-247


How to cite this URL:
Meher BR. Vaccine pharmacovigilance in India: Current context and future perspective. Indian J Pharmacol [serial online] 2019 [cited 2019 Oct 15 ];51:243-247
Available from: http://www.ijp-online.com/article.asp?issn=0253-7613;year=2019;volume=51;issue=4;spage=243;epage=247;aulast=Meher;type=0